Zimmer Biomet wants sales reps to focus on cross-selling opps and non-large joints (FierceMedicalDevices)
(photo courtesy of Ed Siasoco)
Your Dashboard for the Zimmer Biomet Merger
Zimmer Biomet officials spent the newly combined company's Q2 2015 earnings call describing the company's sales and marketing strategy as it seeks to ramp up growth in 2016 following ongoing integration efforts. The company reiterated its pledge to retain sales reps rather than cut them in an effort to achieve synergies.
Instead, Zimmer Biomet aims to appoint 2,000 specialized sales reps in the non-large joints (or non-hip and knee) arena by the end of the year, "a number that we aim to further expand significantly throughout this decade," according to CEO David Dvorak.
"Our vision is to build the most highly specialized and effective musculoskeletal commercial team in the industry. Consistent with that goal, we've selected sales leaders with proven track records and design compensation plans that reward growth. We expect to begin realizing the benefits of our integrated sales channel, as well as these commercial opportunities in the form of sequentially accelerating revenue growth as we exit 2015 and pr...
